Ozols RF - Search Results

1

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.

Roland IH, Yang WL, Yang DH, Daly MB, Ozols RF, Hamilton TC, Lynch HT, Godwin AK, Xu XX. Roland IH, et al. Among authors: ozols rf. Cancer. 2003 Dec 15;98(12):2607-23. doi: 10.1002/cncr.11847. Cancer. 2003. PMID: 14669280 Free article.

2

Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.

Louie KG, Hamilton TC, Shoemaker RH, Young RC, Ozols RF. Louie KG, et al. Among authors: ozols rf. Invest New Drugs. 1992 Jul;10(2):73-8. doi: 10.1007/BF00873120. Invest New Drugs. 1992. PMID: 1500268

3

Ovarian cancer, Part II: Treatment.

Ozols RF. Ozols RF. Curr Probl Cancer. 1992 Mar-Apr;16(2):61-126. Curr Probl Cancer. 1992. PMID: 1617996 Review.

4

Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.

O'Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD, Padavic K, Comis RL, Ozols RF. O'Dwyer PJ, et al. Among authors: ozols rf. J Natl Cancer Inst. 1992 Feb 19;84(4):264-7. doi: 10.1093/jnci/84.4.264. J Natl Cancer Inst. 1992. PMID: 1734088 No abstract available.

5

Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.

Perez RP, O'Dwyer PJ, Handel LM, Ozols RF, Hamilton TC. Perez RP, et al. Among authors: ozols rf. Int J Cancer. 1991 May 10;48(2):265-9. doi: 10.1002/ijc.2910480219. Int J Cancer. 1991. PMID: 2019469

6

Ovarian cancer biology.

Perez RP, Godwin AK, Hamilton TC, Ozols RF. Perez RP, et al. Among authors: ozols rf. Semin Oncol. 1991 Jun;18(3):186-204. Semin Oncol. 1991. PMID: 2042060 Review. No abstract available.

7

Summary of symposium: Biology and therapy of ovarian cancer.

Ozols RF, Hamilton TC, Hoskins WJ, Bast RC Jr, Young RC. Ozols RF, et al. Semin Oncol. 1991 Jun;18(3):297-306. Semin Oncol. 1991. PMID: 2042066 No abstract available.

8

The role of glutathione in drug resistance.

Ozols RF, O'Dwyer PJ, Hamilton TC, Young RC. Ozols RF, et al. Cancer Treat Rev. 1990 Dec;17 Suppl A:45-50. doi: 10.1016/0305-7372(90)90015-8. Cancer Treat Rev. 1990. PMID: 2092870 Review. No abstract available.

9

Multidrug resistance to alkylating agents and platinum compounds: state of our knowledge.

Hamilton TC, Ozols RF, Dabrow MB. Hamilton TC, et al. Among authors: ozols rf. Oncology (Williston Park). 1990 Mar;4(3):101-6; discussion 106, 109. Oncology (Williston Park). 1990. PMID: 2144439 Clinical Trial.

10

Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.

Perez RP, Hamilton TC, Ozols RF. Perez RP, et al. Among authors: ozols rf. Pharmacol Ther. 1990;48(1):19-27. doi: 10.1016/0163-7258(90)90015-t. Pharmacol Ther. 1990. PMID: 2274575 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters